Multifunctional food composition capable of increasing bone density and preparation method of multifunctional food composition

Abstract

The invention belongs to the technical field of health-care foods, and particularly relates to a multifunctional food composition capable of increasing bone density and a preparation method of the multifunctional food composition. The multifunctional food composition consists of the following components in parts by weight of 20-25 parts of dried roots of pueraria lobate, 12-20 parts of Chinese wolfberry fruits, 10-15 parts of dried roots and stems of polygona tum kingianum, polygonatum sibiricum or polygonatum cyrtonema, 4-6 parts of dried roots and stems of dioscorea opposite, 4-6 parts of dried ziziphus jujuba, 2-3 parts of shell of ostrea gigas or ostrea talienwhanensis crosse or ostrearivularis gould, 2-4 parts of colla corii asini, 2-4 parts of rhizoma polygonati odorati, 1-3 parts ofporia cocos, 1-3 parts of dried roots and stems of glycyrrhiza uralensis, or glycyrrhiza inflata or glycyrrhiza glabra, 1-3 parts of dried mature Chaenomeles speciosa and 1-2 parts of coix lacryma-jobi. The raw drug materials have medicinal and edible functions, and have notable curative effects through osteoporosis-resistant experiment on animals. Compared with an estrogens medicine through clinical application, the multifunctional food composition has similar drug effects, and adverse reactions on the liver, the kidney and the like can be notably reduced. Besides, the multifunctional food composition can assist in reducing blood lipid, and improve memory.

Description

technical field [0001] The invention belongs to the technical field of health products, and more specifically relates to a multifunctional food composition for increasing bone density and a preparation method thereof. Background technique [0002] Osteoporosis (Ostcoporosis, OP) is a common and frequently-occurring disease in an aging society. It is a systemic disease characterized by low bone mass and destruction of bone microstructure, resulting in increased bone fragility and prone to fractures. Osteoporosis can usually be divided into three types, including primary osteoporosis, secondary osteoporosis and idiopathic osteoporosis, of which primary osteoporosis accounts for about 90% . Primary osteoporosis can be divided into two types, including postmenopausal osteoporosis and senile osteoporosis. The former is due to the lack of estrogen, which reduces the regulation of calcium-regulating hormones on bone metabolism and the secretion of calcitonin, resulting in weakene...

AI Technical Summary

Problems solved by technology

[0003] At present, the drugs for the treatment of osteoporosis mainly include calcitonin, bisphosphonates, fluoride, vitamin D, calcium and estrogen replacement, etc., but the curative effects are still controversial.

In particular, estrogen replacement therapy has been the first choice for postmenopausal osteoporosis, but with age, the therapeutic effect of estrogen replacement therapy weakens, and long-term use of estrogen can cause endometrial and mammary gland hyperplasia, increase endometrial The risk of cancer, breast and ovarian cancer, and the increased incidence of deep vein thrombosis and pulmonary embolism have severely limited its clinical application

Images